Publications & Works

Articles 49
All (49)
SCI-E, SSCI, AHCI (30)
SCI-E, SSCI, AHCI, ESCI (33)
ESCI (3)
Scopus (33)
TRDizin (13)
Other Publications (4)

41. Cancer stem cells in oncology

JOURNAL OF BUON , vol.17, no.4, pp.644-648, 2012 (SCI-Expanded, Scopus) Sustainable Development
Papers Presented at Peer-Reviewed Scientific Conferences 24

1. Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon

9th International BAU Drug Design Congress, İstanbul, Turkey, 29 November - 02 December 2023, vol.1, no.12, pp.45, (Summary Text)

3. Nab-Paklitaksel ve Parp İnhibitörünün Birlikte Kullanımının Rahim Ağzı Kanser Hücreleri Üzerine In Vitro Etkilerinin Değerlendirilmesi

Zeugma II. Uluslararası Multi Disipliner Çalışmalar Kongresi, Gaziantep, Turkey, 18 - 20 January 2019, vol.1, pp.11-15, (Full Text) Sustainable Development

4. Lipoplatin ve Parp İnhibitörünün Kombin Kullanımının Üçlü Negatif Meme Kanser Hücreleri Üzerine In Vitro Etkilerinin Değerlendirilmesi

Zeugma II. Uluslararası Multi Disipliner Çalışmalar Kongresi, Gaziantep, Turkey, 18 - 20 January 2019, vol.1, no.1, pp.6-10, (Full Text) Creative Commons License Sustainable Development

5. In Vitro Antiproliferative Effects of Topoisomerase Inhibitor CPT-11 on MCF-7 and MDA-MB-231 Breast Cancer Cell Lines

International Symposium on Multidisciplinary Academic Studies, İstanbul, Turkey, 16 - 17 November 2018, pp.249-250, (Full Text) Sustainable Development

7. In Vitro Antiproliferative Effects of LY2109761 on Hela Cell Culture

VI: International Congress of Molecular Medicine, İstanbul, Turkey, 22 May 2017 - 25 May 2018, vol.2, no.1, pp.114, (Full Text)

8. Evaluation cytotoxic and genotoxic effects of some novel synthesized iminothializodinon derivatives on hela cell line (CCL2)

4th International Meeting on Pharmacy & Pharmaceutical Sciences, İstanbul, Turkey, 18 - 21 September 2014, pp.178, (Full Text)

11. The Evaluation of in vitro effect of daunorubicin and tamoxifen in Ehrlich ascites tumour (EAT) Cells

I. Avrasya Nükleer Bilimler ve Uygulamaları Konferansı, İzmir, Turkey, 1 - 04 February 2001, vol.2, pp.743-745, (Full Text)

12. Ehrlich asit sıvısının in vitro koşullarda çoğalma hızını inhibe edici etkisi

XIII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 May 1999, pp.454, (Full Text)

13. Epirubicin ve Tamoksifen'in Ehrlich Ascites Tümör Hücrelerinde 3H-Timidin Damgalanma İndeksine Etkisi

XIII. Ulusal Kanser Kongresi, Antalya, Turkey, 27 April - 01 May 1999, vol.1, pp.87, (Summary Text)

14. Heparin'in FM3A Hücre Kültürlerinde Proliferasyona Etkisi

XIII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 1999, pp.231, (Full Text)

15. Parsiyal Hepatektomili Fare Serumunun L-Hücrelerinin Çoğalma Hızına Etkisi

5. Ulusal Tıbbi Biyoloji Kongresi, İzmir, Turkey, 21 - 24 September 1998, vol.1, pp.37, (Summary Text)

16. Effect of Epirubicin and Tamoxifen on Labelling Index in FM3A Cells

Balkan Congress of Oncology, İzmir, Turkey, 10 - 14 September 1998, vol.3, pp.31, (Summary Text)

17. Epirubicin'in Embriyonik Fare Fibroblast Hücre Kültürlerinde Proliferasyona Etkisi

5. Ulusal Tıbbi Biyoloji Kongresi, İzmir, Turkey, 1 - 04 September 1998, pp.12, (Summary Text)

18. Epirubicin'in FM3A Hücre Kültürlerinde Proliferasyona Etkisi

5. Ulusal Tıbbi Biyoloji Kongresi, İzmir, Turkey, 1 - 04 September 1998, pp.13, (Summary Text)

19. L-strain Hücre Kültürlerinde Farmorubicin'in Mitotik İndeks Açısından Proliferasyon Üzerine Etkisi

XII. Ulusal Kanser Kongresi, Antalya, Turkey, 23 - 26 April 1997, vol.1, pp.287, (Full Text)

20. Embriyonik Fare Fibroblast (EMF) Hücre Kültürlerinde Yaşlanma ve Heparin'in Etkisi

XIII. Ulusal Biyoloji Kongresi, İstanbul, Turkey, 1 - 04 February 1997, vol.III, pp.257-266, (Full Text)

22. Epirubicin'in L-Strain Hücre Kültürlerinde Sentez Fazına Etkisi

4. Ulusal Tıbbi Biyoloji Kongresi, Antalya, Turkey, 1 - 04 June 1996, pp.33, (Summary Text)

23. Effect of epirubicin on H-3-thymidine labelling index in cultured L-strain cells

10th Mediterranean Congress of Chemotherapy, Antalya, Turkey, 20 - 25 October 1996, pp.335-339, (Full Text)

24. Effect of epirubicin and tamoxifen on mitotic and labelling index in Ehrlich Ascites Tumour (EAT) cells

10th Mediterranean Congress of Chemotherapy, Antalya, Turkey, 20 - 25 October 1996, pp.617-620, (Full Text)
Books 10

2. Drug Resistance in Breast Cancer: Subtype-Specific Mechanisms and Strategies to Overcome Treatment Failure

in: Current Developments and Thematic Reviews in Science and Mathematics, Prof. Mustafa Dede, Editor, Platanus Publishing, Ankara, pp.111-133, 2026

3. Epigenetics and Cancer

in: Pioneer and Innovative Research in Health Sciences, Prof. Dr. Fatih HATİPOĞLU, Editor, All Sciences Academy, İstanbul, pp.79-90, 2026

6. Latest Advances in Cancer Stem Cell Research; Treatment Options for Colorectal Cancer

in: Modern Technology Present and Future, Macha M.A., Editor, Omıcs Group Ebooks, Foster City, Usa., pp.1-13, 2015

7. Treatment of Colon Cancer

in: Clinical Diagnosis and Therapy of Colorectal Cancer, Schneider R., Editor, Omics Electric Ebook Publishing, Foster City, pp.1-15, 2015 Sustainable Development

8. The Biology of Cancer Metastasis

in: Cancer: Disease of the age, Ahmed M El-Sharkawy, Editor, Omıcs Group Ebooks, Foster City, pp.1-20, 2015 Sustainable Development

9. Mutation Prevention

in: Cancer Treatment Strategies, Ahmed M. Malki, Editor, Omıcs Group Ebooks, Foster City, pp.1-13, 2015 Sustainable Development

10. Breast Cancer

in: Cancer: Disease of the age, Ahmed M El-Sharkawy, Editor, Omıcs Group Ebooks, Foster City, pp.1-20, 2015 Sustainable Development
Metrics

Publication

84

Publication (WoS)

35

Publication (Scopus)

33

Citation (WoS)

405

H-Index (WoS)

10

Citation (Scopus)

405

H-Index (Scopus)

10

Citation (Scholar)

405

H-Index (Scholar)

10

Project

39

Intellectual Property

2

Thesis Advisory

17

Open Access

21
UN Sustainable Development Goals